Mezigdomide Plus Ixazomib and Dexamethasone for Relapsed and Refractory Multiple Myeloma
Clinical trial NCT06050512 · WITHDRAWN
Trial details
- NCT number
- NCT06050512
- Sponsor
- Kathleen Dorritie
- Status
- WITHDRAWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-02
- Primary completion
- 2026-10-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.